GeneVault is a secure, federated platform for genomic data sharing. Using post-quantum encryption, it lets data owners keep full control while enabling buyers to access only what’s needed—safely, compliantly, and without transferring raw data.
Products, services, technology
GeneVault offers a secure, zero-trust platform for federated genomic data sharing. It enables data owners to retain control, while buyers access encrypted, targeted data via post-quantum-secure queries—ensuring privacy, compliance, and efficient collaboration.
Cooperation possibilities
We welcome cooperation through access to leading genomic datasets and partnerships with biotech, pharma, and academic researchers to develop secure, compliant, and impactful solutions for genomic data sharing and precision medicine.
- https://www.genevault.com/
- +41794289999
- Send an email
- Alex Kummerman
Some insights
GeneVault empowers global genomic research while protecting privacy. By securing data with post-quantum encryption and keeping control with data owners, we enable ethical, compliant, and impactful innovation in medicine, drug discovery, and public health.
We’re proud to lead the way in secure, ethical genomic data sharing. GeneVault enables groundbreaking research without compromising privacy, giving data owners control and researchers the access they need to drive real-world health breakthroughs.
We admire organizations like GA4GH for setting global standards in genomic data sharing, and companies like 23andMe for pioneering public engagement
Our team blends deep expertise in cryptography, genomics, and federated systems. We excel at building secure, scalable infrastructure. Looking ahead, we aim to integrate strengths in AI/ML for genomic insights and regulatory expertise to expand global compliance.
The Swiss biotech ecosystem can support us through strategic partnerships with leading research institutions, access to genomic datasets, and collaboration with biotech, pharma companies, and academic researchers.